(Total Views: 619)
Posted On: 03/08/2022 5:02:26 PM
Post# of 154115
When I got to the 'Pipeline/Overview' tab on the Cytodyn website, I see a graphical representation re: the progress of our current studies.
And it looks to me that - within each vertical trial stage (Pre-Clinical, P1, P2, P3) - the website code lets the user extend the horizontal bar to one of four discrete progress points: 25%, 50%, 75%, 100%.
If so, then it looks like our two Brazil trials are still closer to 25% complete than 50% complete.
I hope I'm wrong - I hope the 25% progress bars don't exactly correlate with our trial enrollments - but since it appears the company is trying to be very conservative in website communications, there's likely a reason they selected the 25% progress point for both studies.
I know it takes a while to review the data once the trial is complete, so maybe that's the last 25% of the progress bar. Best case it would be the last 50% of the progress bar, so that would mean we might actually be close to 50% enrollment.
And it looks to me that - within each vertical trial stage (Pre-Clinical, P1, P2, P3) - the website code lets the user extend the horizontal bar to one of four discrete progress points: 25%, 50%, 75%, 100%.
If so, then it looks like our two Brazil trials are still closer to 25% complete than 50% complete.
I hope I'm wrong - I hope the 25% progress bars don't exactly correlate with our trial enrollments - but since it appears the company is trying to be very conservative in website communications, there's likely a reason they selected the 25% progress point for both studies.
I know it takes a while to review the data once the trial is complete, so maybe that's the last 25% of the progress bar. Best case it would be the last 50% of the progress bar, so that would mean we might actually be close to 50% enrollment.
(1)
(0)
